Search

everythinglearnresearchcommunity

for

Search:↓

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

Antiandrogen therapy helps treat genetic hair loss.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Non-obese women with hair loss have higher heart disease risk.

Monkeys with more anxious or inhibited temperaments tend to have less hair loss.

One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

The document concludes that hair loss in cats is caused by various factors, including allergies, mites, infections, and hormonal issues, with treatments varying accordingly.

Dr. Vera H. Price's 1979 work emphasizes the importance of accurate diagnosis and personalized treatment for hair loss.

Psychotropic drugs can cause hair loss or excessive hair growth.

Hair loss can be reversed or even cured using advanced hair restoration techniques, with rare complications like swelling and bleeding.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

A woman experienced temporary hair loss after jaw surgery due to the stress of the operation.

Hair loss improved with treatment and successful transplant.

COVID-19 can cause significant hair loss.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Aging-related hormone changes affect voice quality, especially during puberty, menstruation, pregnancy, and menopause.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.